Skip to main content
. 2022 Sep 16;54(1):2470–2476. doi: 10.1080/07853890.2022.2121419

Table 3.

Hazard ratios and 95% confidence intervals of Cox proportional-hazards regression analysis during the follow-up of the study cohort.

Characteristics Crude HR
(95% CI)
p-value Adjusted HRa
(95% CI)
p-value Adjusted HRb
(95% CI)
p-value
TB            
 Yes 2.16 (1.82–2.56) <.001 2.16 (1.83–2.56) <.001 9.94 (4.51–21.89) <.001
 No Ref.   Ref.   Ref.  
Age group (years)            
 20–40 Ref.   Ref.   Ref.  
 40–60 1.22 (.80–1.85) .358 1.14 (.75–1.74) .528 1.91 (1.03–3.54) .039
 ≥60 3.41 (2.29–5.09) <.001 3.03 (2.02–4.53) <.001 5.57 (3.06–1.15) <.001
TB and age group            
 With TB and age in 40–60 .28 (.12–.67) .004   .29 (.12–.68) .005
 Without TB and age in 40–60 Ref.     Ref.  
 With TB and age ≥60 .18 (.08–.41) <.001   .18 (.08–.41) <.001
 Without TB and age ≥60 Ref.     Ref.  
Gender            
 Male 1.44 (1.22–1.70) <.001 1.56 (1.33–1.85) <.001 1.57 (1.33–1.85) <.001
 Female Ref.   Ref.   Ref.  
Comorbidity            
 HTN 1.76 (1.52–2.03) <.001 1.29 (1.09–1.52) .002 1.29 (1.10–1.52) .002
 CAD 1.64 (1.34–2.01) <.001 1.10 (.88–1.38) .410 1.10 (.87–1.38) .422
 COPD 2.06 (1.50–2.83) <.001 1.15 (.83–1.60) .409 1.16 (.83–1.61) .382
 HF 2.11 (1.55–2.88) <.001 1.41 (1.02–1.94) .040 1.39 (1.00–1.92) .047
 CVD 1.74 (1.40–2.18) <.001 1.13 (.90–1.43) .299 1.14 (.90–1.43) .285
LR testc, p-value     <.001

CAD: coronary artery disease; CI: confidence interval; COPD: chronic obstructive pulmonary disease; CVD: cerebrovascular disease; HF: heart failure; HR: hazard ratio; HTN: hypertension; LR test: likelihood ratio test; T2DM: type 2 diabetes mellitus; TB: tuberculosis.

aAdjusted for age group, sex, and comorbidity.

bAdjusted for sex and comorbidity and included interaction term with age group.

cLikelihood ratio test for the full model, included interaction term of one characteristic and adjusted for others, and the nested model without interaction term.